Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Rebecca Panks

  • Home
  • Author: Rebecca Panks

COVID-19 exposes fragility of global supply chains but blockchain could be missing link in building resilience, says GlobalData

The COVID-19 pandemic has disrupted nearly every part of supply chains within the healthcare industry, once again exposing the vulnerabilities of many organizations, especially those that have a high dependence on markets such as India and China to meet their raw materials or finished products’ needs. The COVID-19 outbreak is likely to result in healthcare […]
Read more

TUI and HostelWorld suspend dividends to ease financial difficulty, says GlobalData

As banks worldwide cancel dividend payments, more travel-related companies are following suit to keep cash flow circulating in a bid for survival. Both TUI, the European travel giant,and HostelWorld, a hostel-focused online booking platform, are some of the latest travel intermediaries to suspend dividend payments. This is happening industry wide, with major players across hotels, […]
Read more

COVID-19 pandemic delays auctions in Brazil, says GlobalData

The Ministry of Mines and Energy (MEM) in Brazil, has indefinitely postponed the national energy generation and transmission auctions that were scheduled for May, 2020. This includes both the A-4 and A-6 auctions, as well as tenders for transmission lines. Before the pandemic, the nation’s three-year plan comprised an A-4 auction in the first half […]
Read more

Hotels can increase operational efficiency through a range of small-scale initiatives, says GlobalData

Using this current downtime to prepare future operations for a post-COVID-19 business environment is a must for lodging companies, says GlobalData, a leading data and analytics company. Ralph Hollister, Travel & Tourism Analyst at GlobalData, comments: “It has become a necessity for hotel companies to furlough staff, halt expansion plans and impose pay cuts on […]
Read more

Cancer care will be disrupted by COVID-19, says GlobalData

As the COVID-19 pandemic continues to spread across the globe, cancer patients are experiencing disruptions in the treatment of their disease and are being advised to delay chemotherapy, says GlobalData, a leading data and analytics company. Sehrish Rafique PhD, Lead Analyst at GlobalData, comments: “In these uncertain times, medical oncologists must weigh the benefit of […]
Read more

Clinical trials delayed during COVID-19, says GlobalData

There has been an increase in clinical trial delays due to concerns for patient and investigator safety, travel restrictions, subject quarantine, clinical site closures and interrupted supply chains. Numerous aspects of clinical trials are being impacted including enrolment of patients, study start times and initiation of new studies, says GlobalData, a leading data and analytics […]
Read more

US Department of Transportation ruling could be detrimental to airline industry, says GlobalData

Recent instruction by the Department of Transportation will put airlines into further financial difficulty than they already are, says GlobalData, a leading data and analytics company. Rheanna Norris, Associate Analyst at GlobalData, comments: “Airlines rely upon cancellation and change fees as a reliable stream of revenue. The coping mechanism for many US-based airlines has been […]
Read more

Ford engages crisis gear amid bleak outlook, says GlobalData

Following the news that Ford is expecting to make a $600 million first quarter loss and has amassed a $30 billion reserve on its balance sheet; David Leggett, Automotive Editor at GlobalData, a leading data and analytics company, offers his views: “Ford is taking emergency measures – principally in bolstering its cash and liquidity position […]
Read more
,

Slack and Zoom become essential business tools during COVID-19 crisis, says GlobalData

The unprecedented numbers of employees now working from home as a result of the COVID-19 pandemic has caused a 20 times increase in Zoom meetings since January 2020, demonstrating how collaboration software is now a crucial tool for business, says GlobalData, a leading data and analytics company. The coronavirus crisis has propelled collaboration software companies, […]
Read more

Pharmacists authorized to administer coronavirus tests is not the relief the testing chain needs, says GlobalData

Following the authorization of licensed pharmacists by the US Department of Health and Human Services (HHS) to order and administer coronavirus tests; Dara Lo, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “COVID-19 testing is paramount to curbing spread of the disease, yet the US has faced several testing […]
Read more

Global deal activity showed signs of improvement during week ended 5 April, 2020, says GlobalData

Globally, the number of deals announced increased by 29.7% during the week ended 5 April, 2020, compared to the previous week, according to GlobalData’s deals database. Aurojyoti Bose, Lead Analyst at GlobalData, comments: “After registering a few weeks of decline amid volatile market conditions due to the COVID-19 outbreak, the growth in deal announcements has […]
Read more

 UK wind turbine prices might increase post-COVID-19, says GlobalData

According to the UK Government, nearly 15GW of wind projects, primarily offshore, have been classified as ‘awaiting construction’. These are projects waiting to secure viable financing before construction begins. The ongoing disruption caused by the COVID-19 outbreak could prove to be a source of concern for potential investors. Furthermore, round-four offshore wind power auctions have […]
Read more

COVID-19 forcing companies to temporarily bring down the shutters, says GlobalData

Companies across diverse industries and geographies have already started announcing shutdowns. According to leading data and analytics company GlobalData’s news database, the top sectors discussing store closures are automotive and retail, with the automotive industry being one of the worst hit. With the industry working on lean inventory, the prolonged shutdown of auto parts producers […]
Read more

Gilead’s remdesivir better suited to mild-to-moderate COVID-19 patients, says GlobalData

Gilead Sciences’ remdesivir is more likely to work in mild-to-moderate COVID-19 patients rather than severe cases, according to reporting from Reynald Castañeda, Pharma Writer for the Investigative News team at GlobalData, a leading data and analytics company. Castañeda explains: “Given its antiviral mechanism, interviewed experts noted that remdesivir has the potential to decrease viral load in less-severe patients. […]
Read more
1 … 58 59 60 61 62 … 77